• Non ci sono risultati.

Socio-Demographic and other descriptive data for our sample are reported in table 1 and 2:

N/A
N/A
Protected

Academic year: 2021

Condividi "Socio-Demographic and other descriptive data for our sample are reported in table 1 and 2:"

Copied!
17
0
0

Testo completo

(1)

Results

Socio-Demographic and other descriptive data for our sample are reported in table 1 and 2:

Table 1 - Socio-demographic Data (and analysis clusters-”groups”) n=80 Table 1 - Socio-demographic Data (and analysis clusters-”groups”) n=80 Table 1 - Socio-demographic Data (and analysis clusters-”groups”) n=80 Table 1 - Socio-demographic Data (and analysis clusters-”groups”) n=80

Mean (SD) Minimum Maximum

Age 43,5 (11,5) 20 67

Gender Percentage Percentage

Male 33,8% Female 66,3%

Children Percentage Parenthood Percentage

None 47,5 Yes 47,5 1 21,3 2 23,8 3 2,5 No 52,5 4 3,8 7 1,3

Marital Status Percentage Marital Class Percentage

Single 28,8 Alone/Single 37,5 Married 58,8 common-law couple 3,8 Separated 2,5 Couple 62,5 Divorced 3,8 Widowed 2,5

Education Degree Percentage Education Groups Percentage

None 1,3 Non-academic 90

Primary 7,5 Academic 10

Lower Secondary 35,0

Upper Secondary 46,3 Mandatory 44

Bachelor/Master Degree 8,8 High School and Academic 56,3 Doctoral/Master Degree 1,3

(2)

Occupational Status Percentage Occupation Groups Percentage Retired 8,8

Housewife/Student 20,0 Jobless 35

Employed 65,0 Working 65

Unemployed 6,3

Table 2 - Obesity and Comorbidities (n=80) Table 2 - Obesity and Comorbidities (n=80) Table 2 - Obesity and Comorbidities (n=80) Table 2 - Obesity and Comorbidities (n=80)

Comorbidity/Complication Percentage Comorbidity/Complication Percentage

Hypertension 43 Orthopedic 18

Dyslipidemia 31 Gynaecologic/Andrologic Conditions

16

Diabetes Type 2 21 Nefropathy 10

Metabolic Syndrome 38 Hyperuricemia 9

Gastroenterologic 73 Osteopenia/Osteoporosis 9

Steatosis 60 Oncologic History 8

Cardiocirculatory 45 CNS 4

Thyreopathy 31 Rheumatologic conditions 3

OSAHS/Restrictive syndrome

18 PNS 1

Mean BMI (Kg/m2) SD Minimum (Kg/m2) Maximum (Kg/m2)

45 7,65 31 77

Obesity Grade Percentage Obesity Class Percentage

I 3 Moderate (grade I +II) 23

II 20

III 54 Severe/Morbid (grade III) 54

IV 21

V 3 Super/Monstrous

(grade IV+V)

24

(3)

Psychiatric Diagnosis

Prevalence of single psychiatric diagnosis is reported in table 3. It is relevant to point out that every subject with a MINI diagnosis results to suffer from a lifetime mood disorder. Current, Past and Overall Lifetime prevalence of psychiatric disorders rise if BED prevalence data are considered, as shown at the bottom of this table.

In table 4 we see a list of prevalence data by DSM-IV-TR diagnostic categories across different studies, including two general population surveys by De Girolamo and Scott {Malik:2014wx. Comparison with the latter shows a clearly higher current and lifetime prevalence of both mood and general axis I disorders in bariatric surgery candidates when compared to the general population. Our data, when looking at MINI results, show a prevalence of dsm disorders slightly lesser in comparison to literature data (Mauri et al., 2008; Pull, 2010; Wadden et al., 2007). As we already pointed out, the inpatient status of our subjects implies a previous evaluation by at least one expert bariatric surgeon or methabolic/internal medicine specialist: this would have resulted in exclusion of overtly less compliant subjects and, as well, of those bearing severe psychiatric conditions, ; this point alone could well explain the observed difference with other studies.

When we add data from diagnostic interviews and clinical diagnosis of BED, these figures shift towards a higher current prevalence rate of 28,7 %, similar to (and higher than some) literature results (Kalarchian et al., 2007; Mauri et al., 2008; Mitchell et al., 2012; Rosenberger et al., 2006). Looking to lifetime prevalence, again we can find a clean difference between MINI scores, showing a lifetime prevalence of 52,5% and a total DSM prevalence rate of 68,8%. This observation is in line with US and German surveys (Malik et al., 2014). BED prevalence, estimated by DSM criteria

(4)

and confirmed by specific items of the Boston Interview (see above), results higher than literature data

Table 3a - Psychiatric Diagnosis and Therapy (n=80) Table 3a - Psychiatric Diagnosis and Therapy (n=80) Table 3a - Psychiatric Diagnosis and Therapy (n=80) Table 3a - Psychiatric Diagnosis and Therapy (n=80)

MINI 5 Sub Categories % (n)

MINI 5 Sub Categories %

Current Major Depressive Episode

2,5 Lifetime (Hypo)Mania 15

Current Dysthimia 10 Lifetime Unipolar Depression 37,5 Current Hypomania/Mania 0 Lifetime Bipolar Disorder 11,3 Past Major Depressive

Episode(s)

42,5 Negative Mood Disorder History 47,5

Past Hypomania 13,8 Current sub-threshold Panic 6,3

Past Mania 1,3 Panic Disorder History 12,5

Lifetime Depression 48,8 Alcohol abuse, current 1,3

Lifetime Mood History: % %

Bipolar Disorder 9 Manic Epsiodes 3,8

Major Recurrent (unipolar?) Depression

37,5 No Mood History 47,5

Lifetime Panic 12,5

Current BED 17,5 Past BED 42,5

Lifetime BED 46,3

No MINI psychiatric History 47,5 At least 1 MINI LT Diagnosis (always Mood History)

52,5

(5)

Adding up BED prevalence Adding up BED prevalence Adding up BED prevalence Adding up BED prevalence

Current DSM Diagnosis 28,7 Past DSM Diagnosis 65

Lifetime DSM Diagnosis 68,8 BED-Mood comorbidity 30,1

Familial Comorbidity 58,8 History of Psychotropic Medication

20

Patient who received Psychotropic Prescription Patient who received Psychotropic Prescription

Patient who received Psychotropic Prescription 15

Table 3a - M.I.N.I. Axis I and BED Comorbidity Table 3a - M.I.N.I. Axis I and BED Comorbidity Table 3a - M.I.N.I. Axis I and BED Comorbidity Table 3a - M.I.N.I. Axis I and BED Comorbidity Table 3a - M.I.N.I. Axis I and BED Comorbidity

Mood and Panic History (n=80) Bed LT No BED 𝝌2 Sig. LT-Unipolar Depression 19 11 5,951 0,114 LT-Bipolar Disorder 4 5 LT-Mania only 1 1 No Mood History 13 25 LT Panic 7 3 2,593 0,107 No Lt PAnic 30 40

Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies Table 4 - Prevalence comparison with similar studies

Rosenber ger (2006) Rosenber ger (2006) Kalarchia n (2007) Kalarchia n (2007) Mauri (2008) Mauri (2008) Mühlhans (2009) Mühlhans (2009) Mitchell (2012) Mitchell (2012) Our Sample Our Sample De Girolamo 2006/ Demyttena ere 2004 De Girolamo 2006/ Demyttena ere 2004 Scott (2004) Scott (2004) LT Curr . LT Curr . LT Curr . LT Curr. LT Curr . LT Curr . LT Curr . LT Curr . Axis I 36,8 24,1 66,3 37,8 37,6 20,9 72,6 55,5 68,6 33,7 68,8 28,7 18,3 7,3 NA NA Mood 22.4 10,9 45,5 15,6 22 6,4 54,8 31,5 44,2 11,6 52,5 12,5 11,2 3,5 NA 3 Anxiety 15,5 11,5 37,5 24 18,1 12,4 21,2 15,1 31,7 18,1 12,5 6,3 11,1 5,1 NA 2,4 ED 13,8 10,3 29,5 16,3 12,8 7,1 50 37,7 26,6 11,1 46,3 17,5 BED 4,6 3,4 27,1 16 11 6,7 NA 23,3 13,1 10,1 46,3 17,5 EDNOS 9,2 6,9 NA NA NA NA NA 14,4 13,1 NA 21* NA

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

Modified from Malik (2014). (all values are percentage; ED: Any Eating Disorder, BED: Binge Eating Disorders; EDNOS: ED not otherwise specified

(6)

As shown in table 3a, Panic disorder is always comorbid with mood disorders; we didn’t find significant associations between lifetime BED and lifetime Mood Disorders or Panic Disorders.

Group analysis by BED and Axis I general comorbidity

Tables 5- show average domains value differences by Lifetime BED diagnosis (along with Axis I comorbidity).

Table 5: SCL-90 domains and BED Lifetime Table 5: SCL-90 domains and BED Lifetime Table 5: SCL-90 domains and BED Lifetime Table 5: SCL-90 domains and BED Lifetime SCL 90 mean differences SCL 90 mean differences SCL 90 mean differences LT BED No LT Bed F p somatization 21,68 19,45 1,119 0,295 O-C 15,82 13,79 2,474 0,121 interpersonal sensitivity 14,82 12,66 2,024 0,160 depression 20,82 18,83 1,155 0,287 anxiety 15,79 13,45 3,580 0,064 hostility 7,07 7,14 0,018 0,893 phobic anxiety 8,5 8,41 0,014 0,905 paranoid ideation 8,86 7,72 2,249 0,139 psyhoticism 13,14 11,55 4,076 0,048 GSI 1,5379 1,3769 2,198 0,144 PST 89,93 86,9 0,921 0,341 PSDI 1,5379 1,3769 2,198 0,144

The SCL-90 Psychoticism factor shows significantly higher average values in subjects with BED history

Table 6 : Sci-Abs Domains average values Table 6 : Sci-Abs Domains average values Table 6 : Sci-Abs Domains average values Table 6 : Sci-Abs Domains average values Table 6 : Sci-Abs Domains average values

Min Max Mean SD

Attitudes and Beliefes 0 6 1,91 1,468

(7)

Self-Esteem and Satisfaction 0 18 4,71 3,268

Phobias 0 22 7,89 4,716

Avoidant and Compulsive Behaviours 0 8 1,89 1,626

Weight Maintenance 0 17 5,91 3,960

Eating Discontrol 0 19 7,84 5,211

Associated Features and Consequences 0 9 3,68 2,480

Impairment and Insight 0 7 1,11 1,522

Abs Total Score 5 87 36,86 18,21

Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity Table 7 Anorexic-Bulimic Spectrum, BED and Axis I lifetime comorbidity

n=56, mean values LTUD No LTmood LTBD F Sig. Bed LT No BED t Sig. Attitudes and Beliefes 1,81 1,92 2,5 1,084 0,364 1,790 2,040 0,618 0,539 Weight History 1,86 2,04 1,88 0,294 0,829 1,970 1,850 -0,276 0,784 Self-Esteem and Satisfaction 4,14 5,08 5,88 1,322 0,277 4,450 5,000 0,628 0,533 Phobias 6,9 8,8 8,25 0,793 0,503 8,720 7,000 -1,378 0,174 Avoidant and Compulsive Behaviours 1,52 2,28 1,75 0,887 0,454 2,280 1,480 -1,868 0,067 Weight Maintenance 4,9 5,88 8,75 1,922 0,137 6,310 5,480 -0,780 0,439 Eating Discontrol 7,52 8,24 8,63 0,699 0,557 9,480 6,070 -2,583 0,013 Associated Features and Consequences 3,05 3,8 4,75 1,047 0,380 4,210 3,110 -1,679 0,099 Impairment and Insight 0,95 1,4 0,88 0,787 0,507 1,240 0,960 -0,681 0,499

sci-abs total score 32,67 39,44 43,25 1,271 2,940

Sci-abs domains show a statistically significant difference for BED patients, who bear higher scores in the “Eating Discontrol” domain.

(8)

Table 8: Panic-Agoraphobic Spectrum Factors average Values Table 8: Panic-Agoraphobic Spectrum Factors average Values Table 8: Panic-Agoraphobic Spectrum Factors average Values Table 8: Panic-Agoraphobic Spectrum Factors average Values Table 8: Panic-Agoraphobic Spectrum Factors average Values

Min Max Mean SD

Total PAS (cut-off 35) 0 84 23,96 17,943

Panic symptoms 0 28 5,78 5,452

Agoraphobia 0 12 2,78 3,004

Claustrophobia 0 7 2,35 2,188

Separation anxiety 0 9 2,91 2,213

Fear of losing control 0 7 1,49 1,845

Drug sensitivity and phobia 0 8 2,16 2,106 Medical reassurance 0 4 0,49 1,120 Rescue object 0 3 0,84 0,898 Loss sensitivity 0 41 1,67 5,498 Family reassurance 0 3 1,64 1,267

Subjects with positive Total scores

21,3%

Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History Table 9: Panic Spectrum Domains and Axis I History

LT Mood History (mean values) LTUD NO LTMood LTBD LTM F/𝝌2 Sig. Panic symptoms 6,500 5,170 6,670 2,000 0,577 0,633 Agoraphobia 3,590 2,000 3,830 1,500 1,469 0,234 Claustrophobia 3,090 1,830 2,170 2,000 1,343 0,271 Separation anxiety 3,050 3,000 2,330 1,000 0,653 0,585 Fear of losing control* 2,360 1,040 0,330 1,000 3,273 0,029 Drug sensitivity and phobia 2,550 1,920 2,330 1,000 0,544 0,654 Medical reassurance 0,590 0,380 0,830 0,00 0,437 0,728

(9)

Rescue object 1,27>> 0,420 0,830 1,500 4,615 0,006

Loss sensitivity 1,000 2,580 1,170 0,000 0,387 0,763

Family reassurance

1,950 1,500 1,330 0,000 1,867 0,147

Total PAS (cut-off 35)

28,550 21,080 24,000 11,000 1,016 0,394

# of patient over cut-off (21.3%)

10,000 5,000 2,000 0,000 5,111 0,164

*PostHoc Test not stat. significant *PostHoc Test not stat. significant *PostHoc Test not stat. significant *PostHoc Test not stat. significant *PostHoc Test not stat. significant

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

LTUD: lifetime unipolar depression; LTBD: bipolar disorder; LTM Lifetime Mania; NoLTMood: no history of mood disorder

PAS-SR domain fear of losing control shows a significant difference in group comparison (F=3,27; p<0,05) but Post-Hoc analysis didn’t confirm a significant between-groups difference. A greater, and statistically significant difference can be found in the Rescue Object domain, with the unipolar depression history having a significantly higher score than both bipolar and negative mood history groups. Group Comparison for BED history show a statistically significant higher “Drug Sensitivity and Phobia” average score for the BED subgroup.

Table 10: Panic Spectrum Domains and BED History Table 10: Panic Spectrum Domains and BED History Table 10: Panic Spectrum Domains and BED History Table 10: Panic Spectrum Domains and BED History Table 10: Panic Spectrum Domains and BED History

T-test -BED lt (means)

Bed LT No BED t Sig. (2-code)

Panic symptoms 6,800 4,560 1,536 0,130 Agoraphobia 2,900 2,640 0,317 0,753 Claustrophobia 2,570 2,080 0,819 0,416 Separation anxiety 3,200 2,560 1,069 0,290 Fear of losing control 1,800 1,120 1,372 0,176

Drug sensitivity and phobia 2,700 1,520 2,169 0,035 Medical reassurance 0,570 0,400 0,546 0,587 Rescue object 0,830 0,840 -0,027 0,978 Loss sensitivity 1,130 2,320 -0,794 0,431 Family reassurance 1,800 1,440 1,050 0,298

(10)

Table 11: Mood Spectrum Domains scores Table 11: Mood Spectrum Domains scores Table 11: Mood Spectrum Domains scores Table 11: Mood Spectrum Domains scores Table 11: Mood Spectrum Domains scores

MOODS-SR Domains Min Max Mean SD

Psychomotor Activation 0 11 3,27 2,646 Mixed Instability 0 5 1,11 1,590 Spirituality/Mysticism/Psychoticism 0 3 0,35 0,668 Mixed Irritability 0 4 1,05 1,182 Euphoria 0 12 2,07 2,047 Wastefulness/recklessness 0 5 1,09 1,298 Creativity 0 8 3,65 2,545

Inflated Self Esteem 0 4 0,77 1,049

Sociability / Extroversion 0 15 2,84 2,429

Table 11a Moods-SR domains and lifetime BED Table 11a Moods-SR domains and lifetime BED Table 11a Moods-SR domains and lifetime BED Table 11a Moods-SR domains and lifetime BED Table 11a Moods-SR domains and lifetime BED

LT BED No LT BED F Sig.

Psychomotor Activation 3,340 3,210 1,322 0,274 Mixed Instability 1,250 0,970 0,681 0,510 Spirituality/Mysticism/Psychoticism 0,310 0,380 0,357 0,701 Mixed Irritability 1,160 0,940 0,128 0,880 Euphoria 2,090 2,060 0,042 0,959 Wastefulness/recklessness 1,090 1,09 0,325 0,724 Creativity 3,910 3,41 0,181 0,835

Inflated Self Esteem 0,720 0,82 0,084 0,920

Sociability / Extroversion 2,970 2,71 0,389 0,679

(11)

Table 12: Barratt Domains scores Table 12: Barratt Domains scores Table 12: Barratt Domains scores Table 12: Barratt Domains scores Table 12: Barratt Domains scores

Min Max Mean SD

Cognitive Instability 3 14 8,16 3,830 Motor 7 30 17,53 5,523 Perseverance 2 9 4,56 2,000 1st Self Control -26 -7 -18,26 4,220 Cognitive Complexity -9 2 -3,56 2,500 Attentional Impulsivity -5 15 5,21 5,873 Motor Impulsivity 9 38 22,09 6,116 Non-planning Impulsivity -33 -10 -21,82 5,415

Table 13 : Impulsivity Domains and BED History Table 13 : Impulsivity Domains and BED History Table 13 : Impulsivity Domains and BED History Table 13 : Impulsivity Domains and BED History Table 13 : Impulsivity Domains and BED History

LT BED No LT BED F Sig.

Attention -2,53 -3,41 0,823 0,368 Cognitive Instability 8,87 7,37 2,216 0,142 Motor 18,40 16,56 1,602 0,211 Perseverance 4,57 -16,87 0,000 0,984 Self Control* -16,87 -19,81 7,777 0,007 Cognitive Complexity -3,40 -3,74 0,260 0,612 Attentional Impulsivity 6,33 3,96 2,372 0,129 Motor Impulsivity 22,97 21,11 1,316 0,256 Non-planning Impulsivity* -21,61 -18.33 2,407 0,190

The Barratt Impulsivity Scale “Self-Control” Domain shows a significant higher load for patients with BED history.

(12)

Obesity Measures

The following table shows the lack of statistically significant relations between BMI and Lifetime BED, Panic and Mood comorbidity.

Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI Table 14: Axis I Diagnosis and BMI

Yes No F/Student’sT p Bed History 45,17 (n=37) 44,37 (n=43) 0,453 0,652 Lifetime Panic Disorders 43,28 (n=10) 44,95(n=70) -0,783 0,447 Any LT Diagnosis 44,96 (55) 44,26 (25) 0,437 0,664 No Mood History Unipolar LT History Bipolar LT History Isolated Manic Episodes Mean BMI by Mood History 45,58(32) 45,61(25) 42,03(8) 39,35 (2) 0,883 0,455

Even by grouping cases by Obesity Classes (see above) we can’t find any statistically significant differences (Table 15)

Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Table 15: DSM Axis I comorbidity and Obesity Class Obesity Class DSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I DiagnosisDSM Axis I Diagnosis

(n=80) Any LT Axis I No LT Axis I 𝝌2! Sig. BED LT No BED 𝝌2 Sig.

Moderate (grade I +II) 13 5 0,581 0,748 8 10 0,034 0,983

Severe/Morbid (grade III) 28 15 20 23 Super/Monstrous (grade IV+V) 14 5 9 10

(13)

Obesity Class LTUD LTBD NO LT mood 𝝌2 Sig. Lt Panic No Lt Panic 𝝌2 Sig

Moderate (grade I +II) 7 4 6 4,462 0,61 3 15 0,383 0,826

Severe/Morbid (grade III) 15 4 23 5 38 Super/Monstrous (grade IV+V) 8 1 9 2 17

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

(LT BED : lifetime Binge Eating Disorder; LTUD: lifetime unipolar depression; LTBD: bipolar disorder ; LT Panic: history of panic spectrum disorder)

.

Table 16 : BIS Impulsivity domains and Obesity Classes Table 16 : BIS Impulsivity domains and Obesity Classes Table 16 : BIS Impulsivity domains and Obesity Classes Table 16 : BIS Impulsivity domains and Obesity Classes Table 16 : BIS Impulsivity domains and Obesity Classes Table 16 : BIS Impulsivity domains and Obesity Classes

Moderate Ob Severe Ob Morbid Ob F Sig

Attention 0,537 0,587 Cognitive Instability 3 14 8,16 2,994 0,580 Motor# 7 30 17,53 3,800 0,029 Perseverance 2 9 4,56 1,330 0,272 Self Control* -26 -7 -18,26 0,240 0,976 Cognitive Complexity -9 2 -3,56 1,678 0,198 Attentional Impulsivity -5 15 5,21 0,765 0,470 Motor Impulsivity# 9 38>> 22,09 3,836 0,028 Non-planning Impulsivity -33 -10 -21,82 0,449 0,641

(14)

SCI-ABS domain comparison by obesity groups shows a lesser score in “weight history” for patients with moderate (grade 1 or 2) obesity compared to the severe obesity group.

Table 17 Anorexic-Bulimic Spectrum and Obesity Class Table 17 Anorexic-Bulimic Spectrum and Obesity Class Table 17 Anorexic-Bulimic Spectrum and Obesity Class Table 17 Anorexic-Bulimic Spectrum and Obesity Class Table 17 Anorexic-Bulimic Spectrum and Obesity Class Table 17 Anorexic-Bulimic Spectrum and Obesity Class

n=56, mean values Moderate Obesity Severe Obesity Morbid Obesity F Sig.

Attitudes and Beliefes 1,820 2,030 1,710 0,246 0,782

Weight History* 0,91<< 2,190 2,070 3,207 0,048

Self-Esteem and Satisfaction 4,360 4,900 4,570 0,124 0,883

Phobias 4,120 4,440 8,500 0,168 0,846

Avoidant and Compulsive

Behaviours 1,450 1,940 2,140 0,567 0,571

Weight Maintenance 7,650 5,000 6,570 2,145 0,127

Eating Discontrol 6,910 7,450 9,430 0,909 0,409

Associated Features and

Consequences 4,090 3,580 3,570 0,184 0,833

Impairment and Insight 1,270 1,060 1,070 0,078 0,925

(15)

Table 18: Mood Spectrum Factors and Obesity Classes Table 18: Mood Spectrum Factors and Obesity Classes Table 18: Mood Spectrum Factors and Obesity Classes Table 18: Mood Spectrum Factors and Obesity Classes Table 18: Mood Spectrum Factors and Obesity Classes Table 18: Mood Spectrum Factors and Obesity Classes

MOODS Domains (mean)

Moderate Ob Severe Ob Morbid Ob F p

Psychomotor Activation 4,29 2,97 3,07 1,322 0,274 Mixed Instability 0,71 1,14 1,4 0,681 0,510 Spirituality/ Mysticism/ Psychoticism 0,21 0,38 0,4 0,357 0,701 Mixed Irritability 0,93 1,11 1 0,128 0,880 Euphoria 2,21 2,03 2,06 0,042 0,959 Wastefulness/ recklessness 1,07 1,19 0,87 0,325 0,724 Creativity 3,36 3,65 3,93 0,181 0,835

Inflated Self Esteem 0,71 0,76 0,87 0,084 0,920

Sociability / Extroversion

3,14 2,61 3,13 0,389 0,679

Statistical Analysis showed no group differences in moods factorial domains for, DSM diagnosis, Grazing history or Obesity Class.

(16)

Gender

Socio-demographic data, smoke habits, age at hospitalisation appear to be independent of gender, as shown in table 19.

Table 19: Socio-demographic differences by gender Table 19: Socio-demographic differences by gender Table 19: Socio-demographic differences by gender Table 19: Socio-demographic differences by gender

Male % Female%

Sample Composition n=80 33,8% 66,3%

Children % 𝝌2 Sig.

Yes 47,5 1,061 0,30

No 52,5

Marital Class 𝝌2 Sig.

Alone 37,5 0,004 0,951

Couple 62,5

Education Degree % 𝝌2 Sig.

Compulsory 43,7 0,498 0,481

High School and Academic 56,3

Occupational Status % 𝝌2 Sig.

Working 65 1,475 0,225

Not Working 20,0

BMI, Obesity grade and most comorbid conditions or complications don’t show prevalence difference by gender, with some exceptions that reflect general population figures: as expected, Metabolic Syndrome and Hypertension appears equally prevelent between gender groups, Dyslipidaemia, Cardiovascular involvement are significantly more prevalent among men, along with OSAHS/restrictive respiratory syndromes. Thyreopathy, as expected, appears to be more prevalent among women (see Table 20).

(17)

Table 20 : Obesity and associated medical conditions by Gender Table 20 : Obesity and associated medical conditions by Gender Table 20 : Obesity and associated medical conditions by Gender Table 20 : Obesity and associated medical conditions by Gender Table 20 : Obesity and associated medical conditions by Gender

Gender Differences (n=80) Male Female Student’s t / F /𝝌2 p

Mean BMI by gender 46,76 (n=27) 43,72 (n=53) -1,701 0,093

Obesity Class

Moderate (grade I +II) 8 10 2,797 0,247

Severe/Morbid (grade III) 11 32 Super/Monstrous (grade IV+V) 8 11 Associated Conditions* % (n) Metabolic Syndrome 47,7% (n=13) 32,1% (n=13) Dyslipidemia 51,9% (n=14) 20,8% (n=11) 8,051 0,005 Cardiovascular 66,7% (n=18) 30,2% (16) 10,606 0,005 OSAHS/Restrictive Syndromes 37% (n=10) 7,5% (n=4) 10,775 0,001 Thyreopathy 11,1% (n=3) 41,5% (n=22) 7,694 0,006

*associations for all unlisted conditions from Table 2 did not reach statistical significance *associations for all unlisted conditions from Table 2 did not reach statistical significance *associations for all unlisted conditions from Table 2 did not reach statistical significance *associations for all unlisted conditions from Table 2 did not reach statistical significance *associations for all unlisted conditions from Table 2 did not reach statistical significance

All DSM diagnoses and lifetime presence of grazing are also independent of gender, except for current Depressive Episode that appears to be more recurring in men, but weak statistical significance and thin number of cases (only two) warrant caution in weighing this result (Table 21).

Table 21 Psychiatric Diagnosis by Gender Table 21 Psychiatric Diagnosis by Gender Table 21 Psychiatric Diagnosis by Gender Table 21 Psychiatric Diagnosis by Gender Table 21 Psychiatric Diagnosis by Gender

Male Female 𝝌2 p Current Depressive Episode (n=2) 100,0% 0,0% 4,027 0,045 LT Depressive Episode (n=34) 26,5% 73,5% 1,401 0,236 Dysthimia (n=8) 25,0% 75,0% 0,304 0,580 LT Mania (n=12) 41,7% 58,3% 0,396 0,529 LT Panic (n=10) 30,0% 70,0% 0,072 0,789 LT Bed (n=55) 34,5% 65,5% 0,050 0,823 Current BED (n=23) 39,1% 60,9% 0,418 0,518

Figura

Table 2 - Obesity and Comorbidities (n=80)Table 2 - Obesity and Comorbidities (n=80)Table 2 - Obesity and Comorbidities (n=80)Table 2 - Obesity and Comorbidities (n=80)
Table 3a - Psychiatric Diagnosis and Therapy (n=80)Table 3a - Psychiatric Diagnosis and Therapy (n=80)Table 3a - Psychiatric Diagnosis and Therapy (n=80)Table 3a - Psychiatric Diagnosis and Therapy (n=80) MINI 5 Sub Categories %
Table 3a - M.I.N.I. Axis I and BED ComorbidityTable 3a - M.I.N.I. Axis I and BED ComorbidityTable 3a - M.I.N.I
Table 5: SCL-90 domains and BED LifetimeTable 5: SCL-90 domains and BED LifetimeTable 5: SCL-90 domains and BED LifetimeTable 5: SCL-90 domains and BED Lifetime
+7

Riferimenti

Documenti correlati

In the future, after refining the methodology and the investigated phenotypes of lithium pharmacogenetic studies, the prediction of drug efficacy and side effects, using

Venkatraman, Clithero, Fitzsimons, &amp; Huettel (2011) identify six different ways in which Neuroscience can help to improve the prediction of consumers’ choises: Testing

La previsione di una nuova misura coercitiva, il divieto di avvicinamento ai luoghi frequentati dalla persona offesa, è tesa a rafforzare la tutela della vittima

The non-uniform spectral coverage with time can be avoided by the dual configuration, the concentric swarm, achieved by assuming all sensor’s orbit concentric and

In this article we present CWSD (Combined Word Sense Dis- ambiguation), a method and a software tool for enabling automatic anno- tation with lexical information of local structured

The aim of this thesis is the characterization of nanomaterials using a Dynamic Surface Tension Detector (DSTD) and their interactions with Bovine Serum Albumin

La cultura patriarcale ha da sempre valorizzato il ruolo delle sessualità di genere nelle relazioni tra donne e uomini, incoraggiando rappresentazioni tese a immaginare la

uniche imprese che potevano fruire di tale regime erano le società per azioni (S.p.a.) in quanto nel decreto in questione, si fa riferimento solamente ad esse